Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy

Conditions: Anaplastic Thyroid Cancer Interventions: Drug: Dabrafenib + Trametinib Sponsors: Saint Petersburg State University, Russia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials